[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334826-105":59,"doc-detail-334826-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-importance-of-hhla2-in-solid-tumors-a-review-of-the-literature","The Importance of HHLA2 in Solid Tumors - A Review of the Literature","","Cancer immunotherapy focuses on using the host immune system to inhibit and eliminate malignant cells. Antibodies targeting CTLA-4 and the PD-1/PD-L1 axis are widely used, yet the PD-1/PD-L1 pathway shows important limitations and tumors can resist its effects. HHLA2 (B7H5/B7H7/B7y), the newest B7-family molecule, signals through HHLA2/TMIGD2/KIRD3DL3 to regulate immune responses. Evidence indicates a dual function: HHLA2 with TMIGD2 promotes T-cell growth and cytokine production via AKT-dependent signaling, while HHLA2 binding to KIR3DL3 suppresses T cells and supports tumor resistance against NK cells. This review compiles novel HHLA2 findings on immunological mechanisms and clinical relevance of the HHLA2/KIR3DL3/TMIGD2 pathway for cancer treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-importance-of-hhla2-in-solid-tumors-a-review-of-the-literature/334826/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-importance-of-hhla2-in-solid-tumors-a-review-of-the-literature/334826.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this review on HHLA2?","Question",{"text":112,"@type":113},"It summarizes new knowledge about HHLA2 by emphasizing immunological mechanisms and clinical features of the HHLA2/KIR3DL3/TMIGD2 pathway for cancer treatment strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does HHLA2 influence immune responses through TMIGD2?",{"text":117,"@type":113},"HHLA2 together with TMIGD2 promotes T-cell growth and cytokine production via an AKT-dependent signaling cascade.",{"name":119,"@type":110,"acceptedAnswer":120},"How does HHLA2 contribute to tumor resistance via KIR3DL3?",{"text":121,"@type":113},"HHLA2 binding to KIR3DL3 inhibits T cells and mediates resistance against NK cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334826,1790181878,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","cells  \nReview  \nThe Importance of HHLA2 in Solid Tumors—A Review of the Literature  \nAgnieszka Kula 1,*, Dominika Koszewska 2, Anna Kot 2, Miriam Dawidowicz 1, Sylwia Mielcarska 2, Dariusz Waniczek 1 and Elbieta ´Swi˛etochowska 2  \n1 Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland; [d201069@365.sum.edu.pl](d201069@365.sum.edu.pl) (M.D.); [dwaniczek@sum.edu.pl](dwaniczek@sum.edu.pl) (D.W.)  \n2 Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland; [s85874@365.sum.edu.pl](s85874@365.sum.edu.pl) (D.K.); [s85876@365.sum.edu.pl](s85876@365.sum.edu.pl) (A.K.); [d201109@365.sum.edu.pl](d201109@365.sum.edu.pl) (S.M.); [eswietochowska@365.sum.edu.pl](eswietochowska@365.sum.edu.pl) (E.´S .)  \n* Correspondence: [d201070@365.sum.edu.pl](d201070@365.sum.edu.pl)  \nAbstract: Cancer immunotherapy is a rapidly developing field of medicine that aims to use the host’s immune mechanisms to inhibit and eliminate cancer cells. Antibodies targeting CTLA-4, PD-1, and its ligand PD-L1 are used in various cancer therapies. However, the most thoroughly researched pathway targeting PD-1/PD-L1 has many limitations, and multiple malignancies resist its effects. Human endogenous retrovirus-H Long repeat-associating 2 (HHLA2, known as B7H5/B7H7/B7y) is the youngest known molecule from the B7 family. HHLA2/TMIGD2/KIRD3DL3 is one of the critical pathways in modulating the immune response. Recent studies have demonstrated that HHLA2 has a double effect in modulating the immune system. The connection of HHLA2 with TMIGD2 induces T cell growth and cytokine production via an AKT-dependent signaling cascade. On the other hand, the binding of HHLA2 and KIR3DL3 leads to the inhibition of T cells and mediates tumor resistance against NK cells. This review aimed to summarize novel information about HHLA2, focusing on immunological mechanisms and clinical features of the HHLA2/KIR3DL3/TMIGD2 pathway in the context of potential strategies for malignancy treatment.  \nCitation: Kula, A.; Koszewska, D.; Kot, A.; Dawidowicz, M.; Mielcarska, S.; Waniczek, D.; ´Swi˛etochowska, E. The Importance of HHLA2 in Solid Tumors—A Review of the Literature. Cells 2024, 13, 794. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cells13100794](10.3390/cells13100794)  \nAcademic Editor: Alessandro Poggi  \nReceived: 2 April 2024  \nRevised: 2 May 2024  \nAccepted: 5 May 2024  \nPublished: 7 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nKeywords: HHLA2; KIR3DL3; TMIGD2; immunotherapy; immune checkpoint; B7 family  \n1. Introduction  \nThe immune system prevents organisms from developing infections and tumors, and disturbance of its homeostasis mechanisms destroys the protective barrier against cancer development. The interactions of immune cells within the tumor microenvironment induce immunosuppression and lead to the survival and progression of tumors. Immune checkpoint proteins are surface molecules on certain immune cell populations that stimulate or inhibit immune function [1] . Numerous studies have indicated an interaction between the expression of the co-inhibitory protein and tumor immune escape. Consequently, blocking the interaction between an immune checkpoint protein and its ligands emerges asa promising therapeutic approach [2–5] . Cancer immunotherapy is a rapidly developing field of medicine that aims to use the host’s immune mechanisms to inhibit and eliminate cancer cells. This treatment enhances and stimulates humoral and cellular immunity, often leading to lower toxicity","cbCaienviUTy9oCy","https://ap.wps.com/l/cbCaienviUTy9oCy","pdf",1114975,25,"English","# Abstract\n# 1. Introduction\n# 2. B7 Family","[{\"question\":\"What is the main focus of this review on HHLA2?\",\"answer\":\"It summarizes new knowledge about HHLA2 by emphasizing immunological mechanisms and clinical features of the HHLA2/KIR3DL3/TMIGD2 pathway for cancer treatment strategies.\"},{\"question\":\"How does HHLA2 influence immune responses through TMIGD2?\",\"answer\":\"HHLA2 together with TMIGD2 promotes T-cell growth and cytokine production via an AKT-dependent signaling cascade.\"},{\"question\":\"How does HHLA2 contribute to tumor resistance via KIR3DL3?\",\"answer\":\"HHLA2 binding to KIR3DL3 inhibits T cells and mediates resistance against NK cells.\"}]","The Importance of HHLA2 in Solid Tumors - A Review of the Literature | PDF",1790008455,63]